{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T10:11:13Z","timestamp":1784887873839,"version":"3.55.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"NIH NINDS","award":["RO1NS42402"],"award-info":[{"award-number":["RO1NS42402"]}]},{"DOI":"10.13039\/100000102","name":"HRSA","doi-asserted-by":"crossref","award":["DIBTH0632"],"award-info":[{"award-number":["DIBTH0632"]}],"id":[{"id":"10.13039\/100000102","id-type":"DOI","asserted-by":"crossref"}]},{"name":"PA Tobacco Settlement Funds Biomedical Research"},{"DOI":"10.13039\/100000064","name":"NCCAM","doi-asserted-by":"crossref","award":["R21 AT001607"],"award-info":[{"award-number":["R21 AT001607"]}],"id":[{"id":"10.13039\/100000064","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Parkinsonism &amp; Related Disorders"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1016\/j.parkreldis.2010.10.010","type":"journal-article","created":{"date-parts":[[2010,11,12]],"date-time":"2010-11-12T12:19:52Z","timestamp":1289564392000},"page":"34-39","source":"Crossref","is-referenced-by-count":19,"title":["Dyskinesias do not develop after chronic intermittent levodopa therapy in clinically hemiparkinsonian rhesus monkeys"],"prefix":"10.1016","volume":"17","author":[{"given":"Christopher A.","family":"Lieu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milind","family":"Deogaonkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy A.E.","family":"Bakay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thyagarajan","family":"Subramanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.parkreldis.2010.10.010_bib1","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1002\/mds.20360","article-title":"Levodopa-dyskinesia incidence by age of Parkinson\u2019s disease onset","volume":"20","author":"Kumar","year":"2005","journal-title":"Mov Disord"},{"key":"10.1016\/j.parkreldis.2010.10.010_bib2","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1056\/NEJM200103083441002","article-title":"Transplantation of embryonic dopamine neurons for severe Parkinson\u2019s disease","volume":"344","author":"Freed","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.parkreldis.2010.10.010_bib3","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1002\/ana.410250521","article-title":"Pathogenesis of dyskinesias in Parkinson\u2019s disease","volume":"25","author":"Mouradian","year":"1989","journal-title":"Ann Neurol"},{"key":"10.1016\/j.parkreldis.2010.10.010_bib4","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1126\/science.290.5492.767","article-title":"Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson\u2019s disease","volume":"290","author":"Kordower","year":"2000","journal-title":"Science"},{"issue":"Suppl. 1","key":"10.1016\/j.parkreldis.2010.10.010_bib5","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1016\/j.expneurol.2004.08.018","article-title":"Striatal trophic factor activity in aging monkeys with unilateral MPTP-induced parkinsonism","volume":"191","author":"Collier","year":"2005","journal-title":"Exp Neurol"},{"key":"10.1016\/j.parkreldis.2010.10.010_bib6","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/096368979900800113","article-title":"Intranigral transplantation of fetal substantia nigra allograft in the hemiparkinsonian rhesus monkey","volume":"8","author":"Starr","year":"1999","journal-title":"Cell Transplant"},{"key":"10.1016\/j.parkreldis.2010.10.010_bib7","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0963-6897(97)00049-3","article-title":"Polymer-encapsulated PC-12 cells demonstrate high-affinity uptake of dopamine in vitro and 18F-Dopa uptake and metabolism after intracerebral implantation in nonhuman primates","volume":"6","author":"Subramanian","year":"1997","journal-title":"Cell Transplant"},{"key":"10.1016\/j.parkreldis.2010.10.010_bib8","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.ultrasmedbio.2009.12.001","article-title":"Detection of MPTP-induced substantia nigra hyperechogenicity in rhesus monkeys by transcranial ultrasound","volume":"36","author":"Subramanian","year":"2010","journal-title":"Ultrasound Med Biol"},{"key":"10.1016\/j.parkreldis.2010.10.010_bib9","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3727\/000000006783982025","article-title":"Neural repair strategies for Parkinson\u2019s disease: insights from primate models","volume":"15","author":"Soderstrom","year":"2006","journal-title":"Cell Transplant"},{"key":"10.1016\/j.parkreldis.2010.10.010_bib10","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1093\/ilar.48.4.339","article-title":"Nonhuman primate models of Parkinson\u2019s disease","volume":"48","author":"Emborg","year":"2007","journal-title":"ILAR J"},{"key":"10.1016\/j.parkreldis.2010.10.010_bib11","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0009-8981(77)90381-3","article-title":"Simple gas chromatographic analysis of plasma dopa and dopamine","volume":"74","author":"Mizuno","year":"1977","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.parkreldis.2010.10.010_bib12","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/mds.870060205","article-title":"Oral levodopa dose-response study in MPTP-induced hemiparkinsonian monkeys: assessment with a new rating scale for monkey parkinsonism","volume":"6","author":"Kurlan","year":"1991","journal-title":"Mov Disord"},{"key":"10.1016\/j.parkreldis.2010.10.010_bib13","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0304-3940(81)90072-0","article-title":"Evidence for a crossed nigrostriatal pathway in rats","volume":"22","author":"Fass","year":"1981","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.parkreldis.2010.10.010_bib14","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1007\/BF01972287","article-title":"Electrophysiological evidence for the existence of crossed nigrostriatal fibers","volume":"38","author":"Collingridge","year":"1982","journal-title":"Experientia"},{"key":"10.1016\/j.parkreldis.2010.10.010_bib15","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0306-4522(84)90259-8","article-title":"Localization of nigrostriatal, nigrothalamic and nigrotectal neurons in ventricular coordinates in macaques","volume":"13","author":"Francois","year":"1984","journal-title":"Neuroscience"},{"key":"10.1016\/j.parkreldis.2010.10.010_bib16","doi-asserted-by":"crossref","first-page":"a155","DOI":"10.2741\/1104","article-title":"Overlesioned hemiparkinsonian non human primate model: correlation between clinical, neurochemical and histochemical changes","volume":"8","author":"Oiwa","year":"2003","journal-title":"Front Biosci"},{"key":"10.1016\/j.parkreldis.2010.10.010_bib17","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1002\/1531-8249(199911)46:5<732::AID-ANA8>3.0.CO;2-Q","article-title":"Internal globus pallidus discharge is nearly suppressed during levodopa-induced dyskinesias","volume":"46","author":"Papa","year":"1999","journal-title":"Ann Neurol"},{"key":"10.1016\/j.parkreldis.2010.10.010_bib18","doi-asserted-by":"crossref","first-page":"7537","DOI":"10.1523\/JNEUROSCI.1176-08.2008","article-title":"Inversion of dopamine responses in striatal medium spiny neurons and involuntary movements","volume":"28","author":"Liang","year":"2008","journal-title":"J Neurosci"},{"key":"10.1016\/j.parkreldis.2010.10.010_bib19","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.expneurol.2005.10.022","article-title":"Focal striatal dopamine may potentiate dyskinesias in parkinsonian monkeys","volume":"197","author":"Bankiewicz","year":"2006","journal-title":"Experiment Neurol"},{"key":"10.1016\/j.parkreldis.2010.10.010_bib20","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/0006-8993(70)90187-3","article-title":"Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system","volume":"24","author":"Ungerstedt","year":"1970","journal-title":"Brain Res"},{"key":"10.1016\/j.parkreldis.2010.10.010_bib21","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/0306-4522(94)90605-X","article-title":"Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: a combined retrograde tracing and immunocytochemical study in the rat","volume":"59","author":"Sauer","year":"1994","journal-title":"Neuroscience"},{"key":"10.1016\/j.parkreldis.2010.10.010_bib22","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/978-3-211-45295-0_63","article-title":"A new look at levodopa based on the ELLDOPA study","author":"Fahn","year":"2006","journal-title":"J Neural Transm Suppl"},{"key":"10.1016\/j.parkreldis.2010.10.010_bib23","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/mds.870070213","article-title":"Postvaccinal parkinsonism","volume":"7","author":"Alves","year":"1992","journal-title":"Mov Disord"},{"key":"10.1016\/j.parkreldis.2010.10.010_bib24","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/mds.20453","article-title":"Hemiparkinsonism and levodopa-induced dyskinesias after focal nigral lesion","volume":"20","author":"Ruzicka","year":"2005","journal-title":"Mov Disord"},{"key":"10.1016\/j.parkreldis.2010.10.010_bib25","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0022-510X(89)90117-2","article-title":"Drug-induced dyskinesia in primates rendered hemiparkinsonian by intracarotid administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)","volume":"90","author":"Clarke","year":"1989","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.parkreldis.2010.10.010_bib26","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1007\/s002130100733","article-title":"L-dopa induces dyskinesia in normal monkeys: behavioural and pharmacokinetic observations","volume":"156","author":"Pearce","year":"2001","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.parkreldis.2010.10.010_bib27","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/ana.1099","article-title":"Levodopa induces dyskinesias in normal squirrel monkeys","volume":"50","author":"Togasaki","year":"2001","journal-title":"Ann Neurol"},{"key":"10.1016\/j.parkreldis.2010.10.010_bib28","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/00002826-199010000-00006","article-title":"Nigrostriatal damage is required for induction of dyskinesias by L-DOPA in squirrel monkeys","volume":"13","author":"Boyce","year":"1990","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.parkreldis.2010.10.010_bib29","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1002\/mds.870100606","article-title":"Chronic L-DOPA administration induces dyskinesias in the 1-methyl-4- phenyl-1,2,3,6-tetrahydropyridine-treated common marmoset (Callithrix Jacchus)","volume":"10","author":"Pearce","year":"1995","journal-title":"Mov Disord"},{"key":"10.1016\/j.parkreldis.2010.10.010_bib30","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/sj.jcbfm.9600364","article-title":"Subthalamic glutamic acid decarboxylase gene therapy: changes in motor function and cortical metabolism","volume":"27","author":"Emborg","year":"2007","journal-title":"J Cereb Blood Flow Metab"}],"container-title":["Parkinsonism &amp; Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802010002579?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802010002579?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T07:29:59Z","timestamp":1559806199000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802010002579"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["S1353802010002579"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2010.10.010","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]}}}